Last updated on March 2019

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Brief description of study

This is a 16-Week Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 g Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps followed by a 12-Week Open-Label Treatment Phase. The total planned number of subjects is approximately 120 adolescents (12-17 years of age) who will be randomly assigned to receive 1 of 2 study treatments using a 2:1 ratio (OPN-375 186 g: Placebo). For the PK sub-study, up to 14 subjects will be enrolled to obtain 10 completers.

Detailed Study Description

The primary objective of this study is to evaluate the efficacy of intranasal administration of OPN-375 186 g Twice a Day (BID) versus placebo in adolescents with bilateral nasal polyposis and nasal congestion by analyzing the reduction of nasal congestion/obstruction symptoms at the end of Week 4 measured by the 7-day average instantaneous morning diary symptom scores and the reduction in total polyp grade at Week 16 as determined by a nasal polyp grading scale score measured using a 0 to 6 point severity grading scale.

Clinical Study Identifier: NCT03747458

Contact Investigators or Research Sites near you

Start Over

Spokane ENT

Spokane Valley, WA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.